BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37898869)

  • 1. Evaluating the Effectiveness of a Modified Colorectal Cancer Screening Program in Almaty, Kazakhstan.
    Zholmurzayeva R; Ospanova D; Dzhumabekov A; Noso Y; Talkimbayeva N; Aytmanbetova A; Ussebayeva N; Zhorayev T; Fakhradiyev I
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3605-3611. PubMed ID: 37898869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, Attitudes, and Barriers (KABs) of Regarding Colorectal Cancer Screening among the Population of the Republic of Kazakhstan.
    Toleutayeva D; Shalgumbayeva GM; Toleutayev TA; Kudaibergenova NK
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2057-2063. PubMed ID: 35763648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
    Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
    J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.
    Shamsutdinova A; Turdaliyeva B; Tanabayeva S; Omarova A; Saliev T; Tanabayev B; Fakhradiyev I
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2515-2522. PubMed ID: 37505786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of comorbid conditions on adherence to colorectal cancer screening.
    Lukin DJ; Jandorf LH; Dhulkifl RJ; Thélémaque LD; Christie JA; Itzkowitz SH; Duhamel KN
    J Cancer Educ; 2012 Jun; 27(2):269-76. PubMed ID: 22351374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
    Meester RGS; Peterse EFP; Knudsen AB; de Weerdt AC; Chen JC; Lietz AP; Dwyer A; Ahnen DJ; Siegel RL; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2974-2985. PubMed ID: 29846942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.
    Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J
    BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2017 Nov; 123(22):4472-4480. PubMed ID: 28753230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: A randomized controlled trial.
    Hirai K; Ishikawa Y; Fukuyoshi J; Yonekura A; Harada K; Shibuya D; Yamamoto S; Mizota Y; Hamashima C; Saito H
    BMC Public Health; 2016 May; 16():431. PubMed ID: 27220976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.